BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20382725)

  • 1. A tripeptide deletion in the R2 loop of the class C beta-lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to beta-lactamase inhibitors.
    Mallo S; Pérez-Llarena FJ; Kerff F; Soares NC; Galleni M; Bou G
    J Antimicrob Chemother; 2010 Jun; 65(6):1187-94. PubMed ID: 20382725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis.
    Pérez A; Pérez-Llarena FJ; García P; Kerff F; Beceiro A; Galleni M; Bou G
    J Antimicrob Chemother; 2014 Sep; 69(9):2407-11. PubMed ID: 24845871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum beta-lactamases in Escherichia coli.
    Netzel TC; Jindani I; Hanson N; Turner BM; Smith L; Rand KH
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):345-8. PubMed ID: 17379469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.
    Merino M; Pérez-Llarena FJ; Kerff F; Poza M; Mallo S; Rumbo-Feal S; Beceiro A; Juan C; Oliver A; Bou G
    J Antimicrob Chemother; 2010 Sep; 65(9):1950-4. PubMed ID: 20624761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
    Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP
    Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase.
    Kim JY; Jung HI; An YJ; Lee JH; Kim SJ; Jeong SH; Lee KJ; Suh PG; Lee HS; Lee SH; Cha SS
    Mol Microbiol; 2006 May; 60(4):907-16. PubMed ID: 16677302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    Bethel CR; Hujer AM; Helfand MS; Bonomo RA
    FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate.
    Hidri N; Barnaud G; Decré D; Cerceau C; Lalande V; Petit JC; Labia R; Arlet G
    J Antimicrob Chemother; 2005 Apr; 55(4):496-9. PubMed ID: 15722393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the genetic structure and transmission mechanism of a plasmid-mediated AmpC beta-lactamase].
    Lu WX; Wei ZQ; Yu YS; Chen YG; Li LJ
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3043-7. PubMed ID: 16324403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
    Wang Y; Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins.
    Bauernfeind A; Wagner S; Jungwirth R; Schneider I; Meyer D
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2041-6. PubMed ID: 9303413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to the third-generation cephalosporin ceftazidime by a deacylation-deficient mutant of the TEM β-lactamase by the uncommon covalent-trapping mechanism.
    Antunes NT; Frase H; Toth M; Mobashery S; Vakulenko SB
    Biochemistry; 2011 Jul; 50(29):6387-95. PubMed ID: 21696166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).
    Deshpande LM; Jones RN; Fritsche TR; Sader HS
    Int J Antimicrob Agents; 2006 Dec; 28(6):578-81. PubMed ID: 17112706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.